Japan’s Kowa says ivermectin showed ‘antiviral effect’ against Omicron in research
Wait. I was told Joe Rogan lies.
Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other variants of coronavirus in joint non-clinical research.
Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo.
Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy here.
The drug is not approved for treatment of COVID-19 in Japan and the U.S. Federal Drug Administration has repeatedly warned against its use.
- Is the Pope Dying? 2022 Conclave?
- CDC Study — No Significant Difference in COVID-19 Transmission Between Vaccinated and Unvaccinated
- Noooo — Notre-Dame interior faces woke ‘Disney’ revamp
- China Threatens Olympics Athletes Not to Post About Political or Religious Issues…Or Else.
- Hmmm. Four British Airway Pilots Suddenly Die in One Week. But It Has Nothing to do with Vaxx!!!!!!
- 1st Grade Class Read Transgender Book. School Board President, Who Owns Sex Toy Biz, Does Nothing.
- Stupid Salvation Army Goes Woke and Now Broke — Donors Withdraw Support in Response to Racial ‘Wokeness’ Initiative
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- Hey, Whatever Happened to Richard Gere? Oh, He Criticized China.